CME Activities

Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update

By April 29, 2020June 5th, 2020No Comments

CME Activities

"Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update"

Since initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of facial anatomy have greatly increased, leading to rapid advances in treatment plan-ning and implementation.

BoNT-A use has expanded from the upper face to the midface, lower face, and neck, so that BoNT-A injection is the most common cosmetic procedure worldwide. Trends in facial aesthetics reflect growing patient diversity with respect to age, gender, and ethnicity. In October 2019, a multidisciplinary panel of 6 experts in minimally invasive injectable procedures in the special-ties of dermatology and plastic surgery convened at the 2019 American Society for Dermatologic Surgery (ASDS) meeting in Chicago, IL. Their goal was to discuss recent advances in BoNT-A use in facial aesthetics, including implications of the introduction of new agents in light of an evolving patient population.

To receive a CME certificate of participation, you should:

• Read the entire publication, including the CME information.
• Register or log in at www.paradigmmc.com/822 to complete and submit the online posttest and evaluation.

Following online completion of the posttest and evaluation, a certificate of participation will be available for download/printing immediately.

Take CME Now

You May Also Like

Actinic Keratosis: Therapeutic Options and Evolving Considerations

| CME Activities, JDD Webinars | No Comments
Watch Now to Earn 1.0 CE Credit!  Join JDD for Part Two of this two-part webinar series on "Advancing the Understanding of Actinic Keratosis: New Treatment Options and Strategies." In…

Actinic Keratosis: Current Understanding of Pathophysiology and Therapeutic Targets

| CME Activities, JDD Webinars | No Comments
Watch Now to Earn 1.0 CE Credit!  Join JDD for Part One of this two-part webinar series on "Advancing the Understanding of Actinic Keratosis: New Treatment Options and Strategies." In…

What’s New in Topical Treatment for Actinic Keratosis

| CME Activities, JDD Webinars | No Comments
In this one-hour CME webinar, participants will learn the latest information on new topical therapeutic considerations for actinic keratosis, including the recently approved SrC kinase inhibitor. Upon completion of this…

Leave a Reply